Eva J. van Rooden

Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes

Gerjan de Bruin, E.M. Huber, Bo‐Tao Xin et al. · Journal of Medicinal Chemistry · 2014 · 97 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +15

Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB₂ Receptor Expression and Ligand Engagement in Human Cells

Marjolein Soethoudt, Sara Christina Stolze, Matthias V. Westphal et al. · Journal of the American Chemical Society · 2018 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification

Eva J. van Rooden, Bogdan I. Florea, Hui Deng et al. · Nature Protocols · 2018 · 64 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases

Marc P. Baggelaar, Annelot C. M. van Esbroeck, Eva J. van Rooden et al. · ACS Chemical Biology · 2017 · 42 citations

Life Sciences, Biochemistry, Neuroscience +14

Chemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different Mechanisms

Bianka Siewert, Vincent H. S. van Rixel, Eva J. van Rooden et al. · Chemistry - A European Journal · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +12